Skip to main content
SpringerLink
Log in

Inflammatory bowel disease and preterm delivery

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Background

The association between inflammatory bowel disease (IBD) and preterm delivery is controversial. Study size, quality, and design have been inconsistent, making it difficult to assess the relationship between IBD and preterm delivery.

Objective

Utilizing a systematic search of Pubmed for all relevant literature, this review seeks to clarify the correlation between IBD and preterm delivery and to assess the impact of disease activity and medication usage on this outcome.

Results

The available evidence is inadequate to make any robust claims about the association between IBD and preterm delivery. IBD in pregnant women may represent a risk for preterm delivery, and it is probable that IBD activity augments this risk. Many of the medications used to treat IBD also have a correlation with preterm delivery.

Conclusions

While an association between IBD and preterm delivery may exist, further well-designed prospective studies are necessary to determine how the course and management of disease may impact this outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fedorkow DM, Persaud D, Nimrod CA (1989) Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 160(4):998–1001

    Article  PubMed  CAS  Google Scholar 

  2. Nielsen OH, Andreasson B, Bondesen S, Jarnum S (1983) Pregnancy in ulcerative colitis. Scand J Gastroenterol 18(6):735–742

    Article  PubMed  CAS  Google Scholar 

  3. Nielsen OH, Andreasson B, Bondesen S, Jacobsen O, Jarnum S (1984) Pregnancy in Crohn’s disease. Scand J Gastroenterol 19(6):724–732

    PubMed  CAS  Google Scholar 

  4. Baird DD, Narendranathan M, Sandler RS (1990) Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99(4):987–994

    PubMed  CAS  Google Scholar 

  5. Fielding JF, Cooke WT (1970) Pregnancy and Crohn’s disease. Br Med J 2(5701):76–77

    Article  PubMed  CAS  Google Scholar 

  6. Bortoli A, Pedersen N, Duricova D et al (2011) Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003–2006. Aliment Pharmacol Ther 34(7):724–734

    Article  PubMed  CAS  Google Scholar 

  7. Porter RJ, Stirrat GM (1986) The effects of inflammatory bowel disease on pregnancy: a case-controlled retrospective analysis. Br J Obstet Gynaecol 93(11):1124–1131

    Article  PubMed  CAS  Google Scholar 

  8. Dominitz JA, Young JC, Boyko EJ (2002) Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 97(3):641–648

    Article  PubMed  Google Scholar 

  9. Sonntag B, Stolze B, Heinecke A et al (2007) Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis 13(11):1385–1390

    Article  PubMed  Google Scholar 

  10. Khalili H, Ananthakrishnan AN, Higuchi LM, Richter JM, Fuchs CS, Chan AT (2013) Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis 19(3):542–547

    Article  PubMed  Google Scholar 

  11. Nasef NA, Ferguson LR (2012) Inflammatory bowel disease and pregnancy: overlapping pathways. Transl Res 160(1):65–83

    Article  PubMed  CAS  Google Scholar 

  12. Savoye G (2010) Is preterm delivery in inflammatory bowel disease women part of the burden of innate immunity deficiency? Am J Gastroenterol 105(2):473–474

    Article  PubMed  Google Scholar 

  13. Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN (1998) Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 93(12):2426–2430

    Article  PubMed  CAS  Google Scholar 

  14. Kornfeld D, Cnattingius S, Ekbom A (1997) Pregnancy outcomes in women with inflammatory bowel disease–a population-based cohort study. Am J Obstet Gynecol 177(4):942–946

    Article  PubMed  CAS  Google Scholar 

  15. Elbaz G, Fich A, Levy A, Holcberg G, Sheiner E (2005) Inflammatory bowel disease and preterm delivery. Int J Gynaecol Obstet 90(3):193–197

    Article  PubMed  Google Scholar 

  16. Malgarinos G, Gikas A, Delicha E et al (2007) Pregnancy and inflammatory bowel disease: a prospective case-control study. Rev Med Chir Soc Med Nat Iasi 111(3):613–619

    PubMed  CAS  Google Scholar 

  17. Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH (2010) Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring. Inflamm Bowel Dis 16(5):847–855

    Article  PubMed  Google Scholar 

  18. Lin HC, Chiu CC, Chen SF, Lou HY, Chiu WT, Chen YH (2010) Ulcerative colitis and pregnancy outcomes in an Asian population. Am J Gastroenterol 105(2):387–394

    Article  PubMed  Google Scholar 

  19. Stephansson O, Larsson H, Pedersen L et al (2010) Crohn’s disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 8(6):509–515

    Article  PubMed  Google Scholar 

  20. Stephansson O, Larsson H, Pedersen L et al (2011) Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden. Inflamm Bowel Dis 17(3):795–801

    Article  PubMed  Google Scholar 

  21. Oron G, Yogev Y, Shkolnik S et al (2012) Inflammatory bowel disease: risk factors for adverse pregnancy outcome and the impact of maternal weight gain. J Matern Fetal Neonatal Med 25(11):2256–2260

    Article  PubMed  Google Scholar 

  22. Ludvigsson JF, Ludvigsson J (2002) Inflammatory bowel disease in mother or father and neonatal outcome. Acta Paediatr 91(2):145–151

    Article  PubMed  CAS  Google Scholar 

  23. Bortoli A, Saibeni S, Tatarella M et al (2007) Pregnancy before and after the diagnosis of inflammatory bowel diseases: retrospective case-control study. J Gastroenterol Hepatol 22(4):542–549

    Article  PubMed  Google Scholar 

  24. Norgard BM (2011) Birth outcome in women with ulcerative colitis and Crohn’s disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Dan Med Bull 58(12):B4360

    PubMed  Google Scholar 

  25. Raatikainen K, Mustonen J, Pajala MO, Heikkinen M, Heinonen S (2011) The effects of pre- and post-pregnancy inflammatory bowel disease diagnosis on birth outcomes. Aliment Pharmacol Ther 33(3):333–339

    Article  PubMed  CAS  Google Scholar 

  26. Cornish J, Tan E, Teare J et al (2007) A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut 56(6):830–837

    Article  PubMed  CAS  Google Scholar 

  27. Larzilliere I, Beau P (1998) Chronic inflammatory bowel disease and pregnancy. Case control study. Gastroenterol Clin Biol 22(12):1056–1060

    PubMed  CAS  Google Scholar 

  28. Bush MC, Patel S, Lapinski RH, Stone JL (2004) Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 15(4):237–241

    Article  PubMed  CAS  Google Scholar 

  29. Norgard B, Fonager K, Sorensen HT, Olsen J (2000) Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 95(11):3165–3170

    PubMed  CAS  Google Scholar 

  30. Norgard B, Hundborg HH, Jacobsen BA, Nielsen GL, Fonager K (2007) Disease activity in pregnant women with Crohn’s disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol 102(9):1947–1954

    Article  PubMed  Google Scholar 

  31. Friedman S (2007) Medical therapy and birth outcomes in women with Crohn’s disease: what should we tell our patients? Am J Gastroenterol 102(7):1414–1416

    Article  PubMed  Google Scholar 

  32. Morales M, Berney T, Jenny A, Morel P, Extermann P (2000) Crohn’s disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 47(36):1595–1598

    PubMed  CAS  Google Scholar 

  33. Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA (2008) Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 103(5):1203–1209

    Article  PubMed  CAS  Google Scholar 

  34. Diav-Citrin O, Park YH, Veerasuntharam G et al (1998) The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 114(1):23–28

    Article  PubMed  CAS  Google Scholar 

  35. Norgard B, Fonager K, Pedersen L, Jacobsen BA, Sorensen HT (2003) Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut 52(2):243–247

    Article  PubMed  CAS  Google Scholar 

  36. Connell W, Miller A (1999) Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf 21(4):311–323

    Article  PubMed  CAS  Google Scholar 

  37. Paziana K, Del Monaco M, Cardonick E et al (2013) Ciclosporin use during pregnancy. Drug Saf 36(5):279–294

    Article  PubMed  Google Scholar 

  38. Dotan I, Alper A, Rachmilewitz D, et al (2013) Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel. J Crohns Colitis 7(7):542–550

    Google Scholar 

  39. Schnitzler F, Fidder H, Ferrante M et al (2011) Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 17(9):1846–1854

    Article  PubMed  Google Scholar 

  40. Marchioni RM, Lichtenstein GR (2013) Tumor necrosis factor-alpha inhibitor therapy and fetal risk: a systematic literature review. World J Gastroenterol 19(17):2591–2602

    Article  PubMed  CAS  Google Scholar 

  41. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH (2003) The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124(1):9–17

    Article  PubMed  CAS  Google Scholar 

  42. Teruel C, A Lopez-San Roman, Bermejo F et al (2010) Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines. Am J Gastroenterol 105(9):2003–2008

    Article  PubMed  CAS  Google Scholar 

  43. Coelho J, Beaugerie L, Colombel JF et al (2011) Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study. Gut 60(2):198–203

    Article  PubMed  Google Scholar 

  44. Shim L, Eslick GD, Simring AA, Murray H, Weltman MD (2011) The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 5(3):234–238

    Article  PubMed  Google Scholar 

  45. Norgard B, Pedersen L, Christensen LA, Sorensen HT (2007) Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 102(7):1406–1413

    Article  PubMed  Google Scholar 

  46. Cleary BJ, Kallen B (2009) Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A Clin Mol Teratol 85(7):647–654

    Article  PubMed  CAS  Google Scholar 

  47. Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS (2013) Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease. Inflamm Bowel Dis 19(1):15–22

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

No conflict of interest exists.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, POB 151, Beersheba, 84101, Israel

    Bram P. Wispelwey & Eyal Sheiner

Authors
  1. Bram P. Wispelwey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eyal Sheiner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eyal Sheiner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wispelwey, B.P., Sheiner, E. Inflammatory bowel disease and preterm delivery. Arch Gynecol Obstet 288, 725–730 (2013). https://doi.org/10.1007/s00404-013-2989-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-2989-3

Keywords

Search

Navigation